| abstract |
Pharmaceutical compositions comprising soluble CD160 for treating inflammatory conditions involving undesirable immune responses such as tissue graft or organ rejection and autoimmune diseases; infectious and autoimmune diseases, tissue grafts and organs In vitro methods for screening individuals for the presence of inflammatory conditions such as rejection, or the presence of tumors or activated endothelial cells, or therapy of inflammatory conditions such as autoimmune disorders or tissue or organ rejection, Or an in vitro method for monitoring tumors during chemotherapy including treatment with anti-angiogenic agents or antibodies. |